<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01269632</url>
  </required_header>
  <id_info>
    <org_study_id>2009-AO1219-48</org_study_id>
    <nct_id>NCT01269632</nct_id>
  </id_info>
  <brief_title>Cohort of Young Adults Infected With HIV Since Birth or During Childhood</brief_title>
  <acronym>CO19 COVERTE</acronym>
  <official_title>Long Term Evaluation of Young Adults Born to HIV-infected Mothers. A Cohort of Young Adults Infected With HIV Since Birth or During Childhood</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French National Agency for Research on AIDS and Viral Hepatitis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ANRS, Emerging Infectious Diseases</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: With the improvement of the prognosis for HIV-infected infants, thanks to the&#xD;
      availability of antiretroviral therapies, young adults infected with HIV since birth are&#xD;
      becoming an emerging group among the HIV-infected population. Morbidity, mortality and&#xD;
      immunovirological evolution in these young adults need to be studied in a large population&#xD;
      and compared to patients infected with HIV later in adulthood or to the general population in&#xD;
      terms of mortality. Moreover, the study of accelerated or premature ageing, linked to HIV&#xD;
      and/or antiretroviral therapy, is particularly interesting in this population.&#xD;
&#xD;
      Objectives: To study the transition to adulthood and the further evolution of HIV-1 or -2&#xD;
      perinatally infected young adults: 1) To study the teenager to adult transition in terms of&#xD;
      clinical and immunovirological status, schooling and professional integration, sexuality and&#xD;
      reproductive life, transition from paediatrics to adult departments; 2) To study prognosis,&#xD;
      morbidity and mortality according to age, infection stage at the time of antiretroviral&#xD;
      initiation and therapeutic history; 3) To study the incidence and expression of adverse&#xD;
      events and the potential link to antiretroviral therapies; 4) To study the markers of a&#xD;
      potential premature ageing, from the metabolic, cardiovascular and immunological points of&#xD;
      view.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods: A national multicenter cohort of young adults, infected with HIV since birth or&#xD;
      during childhood, including a common module and a physiopathological module (metabolic,,&#xD;
      cardiovascular and immunological). A control group of HIV-uninfected young adults is included&#xD;
      for comparison in the latter module. Patients aged between 18 and 25 years of age, whose HIV&#xD;
      diagnosis was made before the age of 13 are eligible for ANRS CO19 COVERTE. This cohort is an&#xD;
      extension of the EPF cohort (ANRS CO10), in which follow-up stops at the age 18, with an&#xD;
      extension to adults with a HIV diagnosis established before the age of 13. Questionnaires are&#xD;
      filled out by physicians once a year. Self-administered questionnaires are also carried out.&#xD;
      Blood sampling and specific biological exams are collected and a biobank constituted. In the&#xD;
      physiopathological module, specific exams are carried out at inclusion and after 3 years of&#xD;
      follow-up: metabolic and immunological exams, OGTT, CT-scan and DXA-scan, and cardiovascular&#xD;
      explorations (carotid intima-media thickness, pulse wave velocity …). An estimated 400&#xD;
      enrolments during the first 3 years is expected in the common module and an estimated 200&#xD;
      HIV-infected subjects and 75 uninfected controls is expected in the physiopathological&#xD;
      module.&#xD;
&#xD;
      Expected results: The follow-up of young adults in this cohort will bring new data on the&#xD;
      long term efficacy of antiretroviral treatment and their adverse events, from the metabolic,&#xD;
      cardiovascular and immunological, point of view, be they linked or not to HIV infection per&#xD;
      se. This analysis will take into account the characteristics of this population, as compared&#xD;
      to adults infected during adulthood: an early exposure to HIV and antiretroviral treatment, a&#xD;
      different social context, difficulties in care, and a different exposure to risk factors for&#xD;
      adverse events and complications. We will evaluate the impact of the transition to adulthood&#xD;
      and of the transition from paediatrics to adult departments, on clinical prognosis,&#xD;
      adherence, professional and schooling integration, sexuality, social life.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">December 27, 2018</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Immuno virological and clinical prognosis: HIV RNA &lt;50c/mL, CD4 cells count&gt;500 cells/mL, vital status, CDC stage</measure>
    <time_frame>at inclusion and annually up to 06 years follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Professional and schooling integration, social life:marital status, type of accommodation, education level, type and age at first employment</measure>
    <time_frame>at inclusion and annually up to 6 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sexuality, sexual risk behaviour: age at first intercourse, condom use at first, last sexual intercourse, and during last year, unplanned pregnancy, interruption of pregnancy</measure>
    <time_frame>at inclusion and annually up to 6 year follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>metabolic and cardiovascular abnormalities: abnormalities in glucose tolerance and insulino-resistance, dyslipidemia, lipodystrophy, adipocyte dysfunction, atherosclerosis,dysfunction, median of intima media thickness and pulse wave velocity</measure>
    <time_frame>at inclusion and after 3 years follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lymphocyte phenotype and functional capacity of T lymphocyte: description of dysfunctional CMV-specific T cell, T cell responses measured at inclusion, and their evolution during follow-up</measure>
    <time_frame>at inclusion and after 3 years follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">469</enrollment>
  <condition>HIV Infection</condition>
  <condition>Young Adult</condition>
  <arm_group>
    <arm_group_label>HIV infected</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>young adult infected by HIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV uninfected</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>a control group of HIV uninfected young adult will be included for comparison in physiopathological module (metabolic, cardiovascular, and immunological)</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood sampling, specific biological exams and biobank and self administered questionnaires</intervention_name>
    <description>HIV INFECTION at inclusion and annually up to 06 years follow-up&#xD;
clinical and therapeutic evaluation by physician&#xD;
biological: blood sampling, specific biological exams and biobank&#xD;
self administered questionnaires&#xD;
In the physiopathological module: at inclusion and after 3 years follow up: OGTT, CT Scan, Dexa Scan, cardiovascular explorations (carotid intima media thickness, pulse wave velocity, transthoracic echocardiography)&#xD;
HIV UNINFECTED at inclusion and after 3 years follow up&#xD;
clinical evaluation by physician&#xD;
biological: blood sampling, specific biological exams and biobank&#xD;
self administered questionnaires</description>
    <arm_group_label>HIV infected</arm_group_label>
    <arm_group_label>HIV uninfected</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Group of HIV Infection&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 and &lt; 25 years&#xD;
&#xD;
          -  Able to give written consent&#xD;
&#xD;
          -  Covered by French Social Security&#xD;
&#xD;
          -  diagnosis of HIV-1 et/ou-2 documented before age 13&#xD;
&#xD;
        Exclusion Criteria (for physiopathological module only)&#xD;
&#xD;
          -  Under protection(saving) of justice&#xD;
&#xD;
        Control Group&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 and ≤ 25 years&#xD;
&#xD;
          -  Able to give written consent&#xD;
&#xD;
          -  Covered by French Social Security&#xD;
&#xD;
          -  With a brother or sister, cousin, father or mother HIV infected, inbred or adopted&#xD;
&#xD;
          -  With a negative serology for HIV infection, HBV, HCV&#xD;
&#xD;
          -  Without diabetes mellitus&#xD;
&#xD;
          -  able to go to Clinical Investigation Center of Necker and to Hospital St. Antoine for&#xD;
             the recruitment and monitoring&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Under protection(saving) of justice&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hugues Aumaitre</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH PERPIGNAN</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eric Froguel</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital de Lagny</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michèle Bentata</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Avicenne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe Genet</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Argenteuil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olivier Patey</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHIC Villeneuve St Georges</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laurence Gerard</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Louis Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frédéric Lucht</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Etienne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bruno Hoen</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Jacques Besançon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean Luc Schmit</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Nord Amiens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claire Pintado</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Louis Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cécile Goujard</last_name>
    <role>Principal Investigator</role>
    <affiliation>Le Kremlin Bicetre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thierry Allegre</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Aix en Provence</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alain Lafeuillade</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHIC Toulon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre De Truchis</last_name>
    <role>Principal Investigator</role>
    <affiliation>Raymond Poincarré Garches</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vincent Jeantils</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jean Verdier Bondy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claudine Duvivier</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Pasteur</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laurence Slama</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tenon Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olivier Bouchaud</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Avicenne Bobigny</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie Karmochkine</last_name>
    <role>Principal Investigator</role>
    <affiliation>Georges Pompidou Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dominique Salmon Ceron</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cochin Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emmanuel Mortier</last_name>
    <role>Principal Investigator</role>
    <affiliation>Louis Mourier Colombes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roland Tubiana</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pitié Salpétrière Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Marie Girard</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Antoine Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>André Cabié</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Fort de France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean Marie Chennebault</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Angers</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe Morlat</last_name>
    <role>Principal Investigator</role>
    <affiliation>St André Bordeaux</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Weinbreck</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Dupuytren</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laurent Cotte</last_name>
    <role>Principal Investigator</role>
    <affiliation>La Croix Rousse Lyon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sophie Matheron</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bichat Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Véronique Reliquet</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hotel Dieu Nantes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe Pérré</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHD Les Oudairies La Roche Sur Yon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cédric Arvieux</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Pontchaillou Rennes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christine Cheneau</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Strasbourg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martine Obadia</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Purpan Toulouse</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Renaud Verdon</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Cote de Nacre Caen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christine Jacomet</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Gabriel Montpied Clermont Ferrand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lionel Piroth</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Hopital d'enfants Dijon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antoine Chéret</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Tourcoing</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yasmine Debab</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Charles Nicolle Rouen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dominique Merrien</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Compiègne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick Mercié</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU St André Bordeaux</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Valérie Garrait</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHIC Créteil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie Aude Khuong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Général St Denis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Geneviève Beck Wirth</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Mulhouse</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stéphane Blanche</last_name>
    <role>Principal Investigator</role>
    <affiliation>Necker Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Franck Boccara</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Antoine Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claudine Barbuat</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHR Caremeau Nimes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean Paul Viard</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hotel Dieu Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ghislaine Firtion</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cochin Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Albert Faye</last_name>
    <role>Principal Investigator</role>
    <affiliation>Robert Debré Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Catherine Dollfus</last_name>
    <role>Principal Investigator</role>
    <affiliation>Armand Trousseau Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Corinne Floch Tudal</last_name>
    <role>Principal Investigator</role>
    <affiliation>Louis Mourier Colombes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kamila Kebaili</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital de jour ISHOP Lyon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joelle Tricoire</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Paule de Viguier Toulouse</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Françoise Mazingue</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHR Jeanne de Flandres Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pascal Bolot</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHG St Denis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francois Bissuel</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH LC Fleming St Martin Guadeloupe</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anne Chace</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHIC Villeneuve St Georges</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Narcisse Elenga</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHG Andrée Rosemon Cayenne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Natacha Entz Werle</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hautepierre Strasbourg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Girard</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hotel Dieu Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martine Levine</last_name>
    <role>Principal Investigator</role>
    <affiliation>Robert Debré Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Benoit Martha</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Chalon sur Soane</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sandrine Anne Martha</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chalon sur Saone</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrice Poubeau</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHR Réunion St Pierre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean Marc Treluyer</last_name>
    <role>Principal Investigator</role>
    <affiliation>CIC Necker Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Louis Bernard</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Bretonneau Tours</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michel Dupon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Pellegrin Bordeaux</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Zucman</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Foch Suresnes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anne Simon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pitié Salpétrière Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabellle Poizot Martin</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ste Marguerite Marseille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thierry Prazuck</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHR Orléans</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eric Doré</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Estains Clermont Ferrand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Catherine Gaud</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHR Site Felix Guyon Bellepierre La Réunion</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpitaux (voir liste jointe)</name>
      <address>
        <city>De France</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://anrs.fr</url>
    <description>Related Info</description>
  </link>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>September 17, 2010</study_first_submitted>
  <study_first_submitted_qc>January 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2011</study_first_posted>
  <last_update_submitted>December 4, 2020</last_update_submitted>
  <last_update_submitted_qc>December 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>teenagers to adult transition</keyword>
  <keyword>comparison</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

